Apoptosis

, Volume 12, Issue 11, pp 2013–2024 | Cite as

Apoptosis induced by capsaicin in prostate PC-3 cells involves ceramide accumulation, neutral sphingomyelinase, and JNK activation

  • Ana Maria Sánchez
  • Sophie Malagarie-Cazenave
  • Nuria Olea
  • Diana Vara
  • Antonio Chiloeches
  • Inés Díaz-Laviada
Original Paper

Abstract

Numerous studies have recently focused on the anticarcinogenic, antimutagenic, or chemopreventive activities of the main pungent component of red pepper, capsaicin (N-vanillyl-8-methyl-1-nonenamide). We have previously shown that, in the androgen-independent prostate cancer PC-3 cells, capsaicin inhibits cell growth and induces apoptosis through reactive oxygen species (ROS) generation [Apoptosis 11 (2006) 89–99]. In the present study, we investigated the signaling pathways involved in the antiproliferative effect of capsaicin. Here, we report that capsaicin apoptotic effect was mediated by ceramide generation which occurred by sphingomyelin hydrolysis. Using siRNA, we demonstrated that N-SMase expression is required for the effect of capsaicin on prostate cell viability. We then investigated the role of MAP kinase cascades, extracellular signal-regulated protein kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 MAPK, in the antiproliferative effect of capsaicin, and we confirmed that capsaicin could activate ERK and JNK but not p38 MAPK. Pharmacological inhibition of JNK kinase, as well as inhibition of ROS by the reducing agent N-acetylcysteine, prevented ceramide accumulation and capsaicin-induced cell death. However, inhibition of ceramide accumulation by the SMase inhibitor D609 did not modify JNK activation. These data reveal JNK as an upstream regulator of ceramide production. Capsaicin-promoted activation of ERK was prevented with all the inhibitors tested. We conclude that capsaicin induces apoptosis in PC-3 cells via ROS generation, JNK activation, ceramide accumulation, and second, ERK activation.

Keywords

Capsaicin Apoptosis Ceramide Neutral sphingomyelinase JNK ERK PC-3 cells RNA silencing 

Notes

Acknowledgments

Authors thank the collaboration of Unidad de Cultivos from Universidad de Alcalá. This study was supported by grants from the Spanish Ministerio de Educación y Ciencia (SAF2005-00602), from UAH-CAM (CCG06-UAH/SAL-0562) and from Comunidad de Madrid (S-SAL-0261-2006). AMS and SMC are fellows from Spanish Ministerio de Educación y Ciencia. NO and DV have a fellowship from University of Alcalá.

References

  1. 1.
    Carson CC (2006) Carcinoma of the prostate: overview of the most common malignancy in men. N C Med J 67:122–127PubMedGoogle Scholar
  2. 2.
    Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ (2006) Cancer statistics, 2007 CA Cancer J Clin 56:106–130PubMedCrossRefGoogle Scholar
  3. 3.
    Wang G, Reed E, Li QQ (2004) Apoptosis in prostate cancer: progressive and therapeutic implications. Int J Mol Med 14:23–34PubMedGoogle Scholar
  4. 4.
    Talalay P, Fahey JW (2001) Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism. J Nutr 131:3027S–3033SPubMedGoogle Scholar
  5. 5.
    Tuoya, Baba N, Shimoishi Y, Murata Y, Tada M, Koseki M, Takahata K (2006) Apoptosis induction by dohevanil, a DHA substitutive analog of capsaicin, in MCF-7 cells. Life Sci 78:515–519CrossRefGoogle Scholar
  6. 6.
    Jung MY, Kang HJ, Moon A (2001) Capsaicin-induced apoptosis in SK-Hep-1 hepatocarcinoma cells involves Bcl-2 downregulation and caspase-3 activation. Cancer Lett 165:139–145PubMedCrossRefGoogle Scholar
  7. 7.
    Qiao S, Li W, Tsubouchi R, Haneda M, Murakami K, Yoshino M (2005) Involvement of peroxynitrite in capsaicin-induced apoptosis of C6 glioma cells. Neurosci Res 51:175–183PubMedCrossRefGoogle Scholar
  8. 8.
    Tsou MF, Lu HF, Chen SC, Wu LT, Chen YS, Kuo HM, Lin SS, Chung JG (2006) Involvement of Bax, Bcl-2, Ca2+ and caspase-3 in capsaicin-induced apoptosis of human leukemia HL-60 cells. Anticancer Res 26:1965–1971PubMedGoogle Scholar
  9. 9.
    Wu CC, Lin JP, Yang JS, Chou ST, Chen SC, Lin YT, Lin HL, Chung JG (2006) Capsaicin induced cell cycle arrest and apoptosis in human esophagus epidermoid carcinoma CE 81T/VGH cells through the elevation of intracellular reactive oxygen species and Ca2+ productions and caspase-3 activation. Mutat Res 601:71–82PubMedGoogle Scholar
  10. 10.
    Sánchez AM, Sánchez MG, Malagarie-Cazenave S, Olea N, Díaz-Laviada I (2006) Induction of apoptosis in prostate tumor PC-3 cells and inhibition of xenograft prostate tumor growth by the vanilloid capsaicin. Apoptosis 11:89–99PubMedCrossRefGoogle Scholar
  11. 11.
    Reinehr R, Becker S, Braun J, Eberle A, Grether-Beck S, Haussinger D (2006) Endosomal acidification and activation of NADPH oxidase isoforms are upstream events in hyperosmolarity-induced hepatocyte apoptosis. J Biol Chem 281:23150–23166PubMedCrossRefGoogle Scholar
  12. 12.
    Andrieu-Abadie N, Levade T (2002) Sphingomyelin hydrolysis during apoptosis. Biochim Biophys Acta 1585:126–134PubMedGoogle Scholar
  13. 13.
    Pettus BJ, Chalfant CE, Hannun Y (2002) Ceramide in apoptosis: an overview and current perspectives. Biochim Biophys Acta 1585:114–125PubMedGoogle Scholar
  14. 14.
    Levade T, Malagarie-Cazenave S, Gouaze V, Segui B, Tardy C, Betito S, Andreieu-Abadie N, Culliver O (2002) Ceramide in apoptosis: a revisited role. Neurochem Res 27:601–607PubMedCrossRefGoogle Scholar
  15. 15.
    Bielawska A, Perry DK, Hannun YA (2001) Determination of ceramides and diglycerides by the diglyceride kinase assay. Anal Biochem 298:141–150PubMedCrossRefGoogle Scholar
  16. 16.
    Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911–917PubMedGoogle Scholar
  17. 17.
    Malagarie-Cazenave S, Ségui B, Lévêque S, Garcia V, Carpentier S, Altié M, Brouchet A, Gouazé V, Andrieu-Abadie N, Barreira Y, Benoist H, Levade T (2004) Role of FAN in tumor necrosis factor-alpha and lipopolysaccharide-induced interleukin-6 secretion and lethality in d-galactosamine-sensitized mice. Biol Chem 279:18648–18655CrossRefGoogle Scholar
  18. 18.
    Clarke CJ, Snook CF, Tani M, Matmati N, Marchesini N, Hannun YA (2006) The extended family of neutral aphingomyelinases. Biochemistry 45:11247–11256PubMedCrossRefGoogle Scholar
  19. 19.
    Sells SF, Wood DP (1994) Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and -independent prostate cells. Cell Growth Differ 5:457–466PubMedGoogle Scholar
  20. 20.
    Goswami A, Ranganathan P, Rangnekar VM (2006) The phosphoinositide 3-kinase/Akt1/Par-4 axis: a cancer-selective therapeutic target. Cancer Res 66:2889–2892PubMedCrossRefGoogle Scholar
  21. 21.
    Srinivasan S, Ranga RS, Burikhanov R, Han S, Chendil D (2007) Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells. Cancer Res 67:246–253PubMedCrossRefGoogle Scholar
  22. 22.
    Mori A, Lehmann S, O’Kelly J, Kumagai T, Desmond J, Pervan M, McBride WH, Kizaki M, Koeffler HP (2006) Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells. Cancer Res 66:3222–3229PubMedCrossRefGoogle Scholar
  23. 23.
    Sultan I, Senkal CE, Ponnusamy S, Bielawski J, Szulc Z, Bielawska A, Hannun YA, Ogretmen B (2006) Regulation of the sphingosine-recycling pathway for ceramide generation by oxidative stress, and its role in controlling c-Myc/Max function. Biochem J 393:513–521PubMedCrossRefGoogle Scholar
  24. 24.
    Won JS, Singh I (2006) Sphingolipid signaling and redox regulation. Free Radic Biol Med 40:1875–1888PubMedCrossRefGoogle Scholar
  25. 25.
    Navas P, Villalba JM, Cabo R (2007) The importance of plasma membrane coenzyme Q in aging and stress responses. Mitochondrion 7 Suppl 1:S34–S30Google Scholar
  26. 26.
    Clarke CJ, Hannun YA (2006) Neutral sphingomyelinases and nSMase2: bridging the gaps. Biochim Biophys Acta 1758:1893–1901PubMedCrossRefGoogle Scholar
  27. 27.
    De Luca T, Morré DM, Zhao H, Morré DJ (2005) NAD+/NADH and/or CoQ/CoQH2 ratios from plasma membrane electron transport may determine ceramide and aphingosine-1 phosphate levels accompanying G1 arrest and apoptosis. BioFactors 25:43–46PubMedGoogle Scholar
  28. 28.
    Morre J, Chueh P, Morré DM (1995) Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture. Proc Natl Acad Sci USA 92:1831–1835PubMedCrossRefGoogle Scholar
  29. 29.
    Shida Y, Igawa T, Hakariya T, Sakai H, Kanetake H (2007) p38 MAPK activation is involved in androgen-independent proliferation of human prostate cancer cells by regulating IL-6 secretion. Biochem Biophys Res Commun 353:744–749PubMedCrossRefGoogle Scholar
  30. 30.
    Ricote M, García-Tuñón I, Bethencourt F, Fraile B, Onsurbe P, Paniagua R, Royuela M (2006) The p38 transduction pathway in prostatic neoplasia. J Pathol 208:401–407PubMedCrossRefGoogle Scholar
  31. 31.
    Bubici C, Papa S, Dean K, Franzoso G (2006) Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance. Oncogene 25:6731–6748PubMedCrossRefGoogle Scholar
  32. 32.
    Shen H, Liu Z (2006) JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species. Free Radic Biol Med 40:928–939PubMedCrossRefGoogle Scholar
  33. 33.
    Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, Ichijo H (1998) Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 17:2596–2606PubMedCrossRefGoogle Scholar
  34. 34.
    Zhuang S, Schnellmann RG (2006) A death-promoting role for extracellular signal-regulated kinase. J Pharmacol Exp Ther 319:991–997PubMedCrossRefGoogle Scholar
  35. 35.
    Galve-Roperh I, Sanchez C, Cortes ML, del Pulgar TG, Izquierdo M, Guzman M (2000) Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat Med 6:313–319PubMedCrossRefGoogle Scholar
  36. 36.
    Tanel A, Averill-Bates DA (2006) P38 and ERK mitogen-activated protein kinases mediate acrolein-induced apoptosis in Chinese hamster ovary cells. Cell Signal 19(5):968–977PubMedCrossRefGoogle Scholar
  37. 37.
    Wang X, Martindale JL, Holbrook NJ (2000) Requirement for ERK activation in cisplatin-induced apoptosis. J Biol Chem 275:39435–39443PubMedCrossRefGoogle Scholar
  38. 38.
    Woessmann W, Chen X, Borkhardt A (2002) Ras-mediated activation of ERK by cisplatin induces cell death independently of p53 in osteosarcoma and neuroblastoma cell lines. Cancer Chemother Pharmacol 50:397–404PubMedCrossRefGoogle Scholar
  39. 39.
    Choi BK, Choi CH, Oh HL, Kim YK (2004) Role of ERK activation in cisplatin-induced apoptosis in A172 human glioma cells. Neurotoxicology 25:915–924PubMedCrossRefGoogle Scholar
  40. 40.
    Jeon ES, Lee MJ, Sung SM, Kim JH (2007) Sphingosylphosphorylcholine induces apoptosis of endothelial cells through reactive oxygen species-mediated activation of ERK. J Cell Biochem 100:1536–1547PubMedCrossRefGoogle Scholar
  41. 41.
    Sheu LF, Young ZH, Lee WC, Chen YF, Kao WY, Chen A (2007) STI571 sensitizes nasopharyngeal carcinoma cells to cisplatin: sustained activation of ERK with improved growth inhibition. Int J Oncol 30:403–411PubMedGoogle Scholar
  42. 42.
    Oh HL, Seok JY, Kwon CH, Kang SK, Kim YK (2006) Role of MAPK in ceramide-induced cell death in primary cultured astrocytes from mouse embryonic brain. Neurotoxicology 27:31–38PubMedCrossRefGoogle Scholar
  43. 43.
    Gurumurthy S, Rangnekar VM (2004) Par-4 inducible apoptosis in prostate cancer cells. J Cell Biochem 91:504–512PubMedCrossRefGoogle Scholar
  44. 44.
    Bieberich E (2004) Integration of glycosphingolipid metabolism and cell-fate decisions in cancer and stem cells: review and hypothesis. Glycoconj J 21:315–327PubMedCrossRefGoogle Scholar
  45. 45.
    Bieberich E, Silva J, Wang G, Krishnamurthy K, Condie BG (2004) Selective apoptosis of pluripotent mouse and human stem cells by novel ceramide analogues prevents teratoma formation and enriches for neural precursors in ES cell-derived neural transplants. J Cell Biol 167:723–734PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Ana Maria Sánchez
    • 1
  • Sophie Malagarie-Cazenave
    • 1
  • Nuria Olea
    • 1
  • Diana Vara
    • 1
  • Antonio Chiloeches
    • 1
  • Inés Díaz-Laviada
    • 1
  1. 1.Department of Biochemistry and Molecular Biology, School of MedicineUniversity of AlcaláAlcalá de HenaresSpain

Personalised recommendations